Henan Purui Pharmaceutical

Henan Purui Pharmaceutical is a Chinese pharmaceutical manufacturer focused on active pharmaceutical ingredients, pharmaceutical intermediates, and finished-dose products including tablets, capsules, and injections. The company appears to operate primarily as a commercial-stage generic pharma and API supplier rather than a novel-drug biotech developer. Publicly available sources describe strengths in anticholinergic APIs and other small-molecule products such as atropine sulfate, racemic anisodamine, levofloxacin hydrochloride, fluconazole, piroxicam, clopidogrel hydrogen sulfate, and atorvastatin calcium. Henan Purui has GMP-certified operations in Xihua County, Henan, has filed DMFs for selected APIs for the U.S. market, and markets products domestically in China with some export orientation. The company also reports long-term collaborations with Chinese academic institutions and has invested in additional manufacturing capacity in Henan.